Skip to main content
    A

    Align Technology Inc (ALGN)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $163.46
    -2.52 (-1.52%)

    Market Cap: $11.70B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Align Technology Inc (ALGN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Align Technology (ALGN) has a market cap of $11.70B and an enterprise value of $10.55B. Its trailing P/E of 15.9x is below its 10-year median of 42.8x.

    Total Valuation

    Enterprise value is 9.79% below the market cap, as cash exceeds debt.

    Market Cap$11.70B
    Enterprise Value$10.55B
    Latest price (Nov 17, 2026)$163.46

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateOct 28, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.70% in the quarter ended Sep 30, 2026 and shrank 2.54% a year over 2 years.

    Shares Outstanding70.99M
    Shares Change (YoY)-1.91%
    Shares Change (QoQ)-0.70%
    Share Count Growth (2Y CAGR)-2.54%

    Valuation Ratios

    Sales and book value multiples are 2.8x and 2.7x. Its year-end P/E ranged from 14.8x to 102.0x from 2016 to 2025.

    P/E Ratio15.9x
    Forward P/E14.5x
    P/S Ratio2.8x
    Forward P/S2.8x
    P/B Ratio2.7x
    P/TBV Ratio3.1x
    P/FCF Ratio19.3x
    P/OCF Ratio15.6x
    PEG Ratio1.2

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 12.1x EBITDA and 17.4x free cash flow.

    EV / Earnings21.5x
    EV / Sales2.5x
    EV / EBITDA12.1x
    EV / FCF17.4x

    Price Statistics

    The stock is up 19.20% over 52 weeks and trades 7.53% above its 50-day average.

    Beta (1Y)1.30
    52-Week Change+19.20%
    1-Month Change+9.70%
    3-Month Change+0.26%
    6-Month Change+5.35%
    5-Year Change-75.99%
    10-Year Change+74.45%
    Total Return (1Y)+19.20%
    Total Return (3Y CAGR)-7.51%
    Total Return (5Y CAGR)-24.91%
    Return vs SPY (1Y)+12.01%
    Max Drawdown (1Y)-29.18%
    Max Drawdown (3Y)-62.19%
    Sharpe Ratio (1Y)0.53
    Correlation with SPY (1Y)0.45
    50-Day Average$152.02
    200-Day Average$168.69
    52-Week Range$131.95 to $200.44
    RSI (14 Days)54.9
    Average Volume (20 Days)1.20M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.42x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.42x
    Quick Ratio1.31x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 11.42% over the last 12 months, against a 5-year average of 12.94%.

    Return on Equity (ROE)11.42%
    Return on Assets (ROA)7.54%
    ROE (5Y Average)12.94%
    ROA (5Y Average)7.95%
    ROIC (5Y Average)12.45%
    Asset Turnover0.65x
    Inventory Turnover5.88x
    Receivables Turnover3.60x
    Cash Conversion Cycle131 days

    Taxes

    Income tax took 23.65% of pretax income over the last 12 months.

    Income Tax (TTM)$152.38M
    Effective Tax Rate23.65%

    Scores

    ALGN has an Altman Z-Score of 4.81, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score4.81
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $4.16B over the last 12 months is up 4.42% from the 12 months before.

    Revenue$4.16B
    Revenue Growth (YoY)+4.42%
    Gross Profit$2.88B
    Operating Income$620.46M
    Pretax Income$644.25M
    Net Income$491.87M
    EBITDA$862.99M
    Reported EPS (TTM)$10.29

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 66.10% of the $6.52B in total assets.

    Cash and Equivalents$1.14B
    Total Debt$0
    Net Cash$1.14B
    Net Cash Per Share$16.13
    Working Capital$812.58M
    Shareholder Equity$4.31B
    Book Value Per Share$60.65
    Tangible Book Value$3.72B
    Tangible Book Per Share$52.39
    Total Assets$6.52B
    Total Liabilities$2.22B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $147.39M of capital spending, operating cash flow left $602.50M of free cash flow.

    Operating Cash Flow$749.89M
    Capital Expenditures$147.39M
    Free Cash Flow$602.50M
    FCF Per Share$8.48
    Depreciation and Amortization$238.12M
    Share Repurchases$298.44M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 14.92%, against a 5-year average of 17.46%.

    Gross Margin69.14%
    Operating Margin14.92%
    Pretax Margin15.49%
    Net Margin11.83%
    EBITDA Margin20.75%
    FCF Margin14.49%
    Gross Margin (5Y Average)70.41%
    Operating Margin (5Y Average)17.46%
    Net Margin (5Y Average)12.29%

    Growth

    Revenue grew 2.61% a year over 3 years, and EPS 13.37% a year.

    Revenue Growth (3Y CAGR)+2.61%
    Revenue Growth (5Y CAGR)+10.30%
    EPS Growth (3Y CAGR)+13.37%
    EPS Growth (5Y CAGR)+14.96%
    FCF Growth (3Y CAGR)+21.03%
    FCF Growth (5Y CAGR)-0.66%
    Operating Income Growth (3Y CAGR)-5.30%
    Book Value Per Share Growth (2Y CAGR)+8.54%
    Tangible Book Per Share Growth (2Y CAGR)+8.14%

    Revenue and profit by year

    Dividends and Yields

    ALGN does not pay a dividend. Its free cash flow yield is 5.19%.

    Earnings Yield6.29%
    FCF Yield5.19%
    Buyback Yield2.40%
    Shareholder Yield2.40%

    Peer Position

    Against 11 similar companies, ALGN has the 9th highest P/E and the 7th highest P/S.

    P/E Ratio15.9x vs 20.7x median
    P/S Ratio2.8x vs 2.9x median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.42% vs +9.01% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 2.55% and EPS growth at 8.08% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2.55%
    EPS Growth Forecast (2Y CAGR)+8.08%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ALGN

    What is ALGN's market cap?

    Align Technology has a market cap of $11.70B. Its enterprise value, which adds debt and subtracts cash, is $10.55B.

    What is ALGN's P/E ratio?

    Align Technology has a trailing P/E ratio of 15.9x and a forward P/E of 14.5x.

    How many shares of ALGN are outstanding?

    Align Technology has 70.99M shares outstanding. The count is down 1.91% from a year earlier.

    Does ALGN pay a dividend?

    No. Align Technology does not pay a dividend.

    How much debt does ALGN have?

    Align Technology has $0 of total debt and $1.14B of cash and equivalents, a net cash position of $1.14B.